NCT02732158
Completed
Not Applicable
Feasibility of Novel Laboratory Methods for Use in Nutrition Studies
ConditionsHealthy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Healthy
- Sponsor
- Abbott Nutrition
- Enrollment
- 55
- Locations
- 1
- Primary Endpoint
- Comparison of lab values from venipuncture and DBS methods
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
This prospective, nonrandomized, feasibility study will compare laboratory measures at the beginning and end of the study period in adults consuming a nutritional study product.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participant must agree to refrain from taking supplements other than study product.
- •Participant states willingness to follow protocol as described, including consumption of study product per protocol, performing finger stick/DBS on Day 60 and completing any forms needed throughout the study.
Exclusion Criteria
- •Body Mass Index (BMI) \> or equal to 35 kg/m2
- •Has planned elective surgery requiring 2 or more days of hospitalization during the entire study
- •Has stated active malignant disease
- •Has a known history of chronic renal parenchymal disease
- •Has a known history of severe liver disease/liver failure
- •Has any psychiatric disorders that would interfere with study product consumption or compliance with the study procedures
- •Known allergy or intolerance to any study product ingredient
- •Participation in another study that has not been approved as a concomitant study
Outcomes
Primary Outcomes
Comparison of lab values from venipuncture and DBS methods
Time Frame: Baseline
Correlation and difference in baseline levels of AN777 and carotenoids between samples collected through venipuncture and fingerstick on dried blood spot (DBS) cards.
Secondary Outcomes
- Change in carotenoids(Baseline to Day 60)
- Change in AN777(Baseline to Day 60)
- Compliance of study product consumption(Baseline to Day 60)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
NEWBIE Validate: Feasibility of a New Test to Measure Glucose in Newborn Blood Spots (NBS)Neonatal DiabetesNCT04831723Royal Devon and Exeter NHS Foundation Trust10,784
Not yet recruiting
Not Applicable
CAtaract ASSessment of IntrOcular Lens Objective PErformancECataractNCT06168617Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts75
Completed
Not Applicable
Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes ComplicationsType 1 DiabetesType 2 DiabetesNCT01415115VeraLight, Inc.250
Active, not recruiting
Not Applicable
Pilot study to establish laboratory methods for urine Nerve Growth Factor (NGF) and immunohistochemical staining of the vanilloid receptor (TRPV1) in bladder biopsies, following open label treatment with botulinum neurotoxin type A in patients with neurogenic detrusor overactivity (NDO) and idiopathic detrusor overactivity (IDO). - Bladder biopsies from pts receiving BoNT/A injections for NDO and IDOeurogenic & Idiopathic detrusor overactivity in the bladderMedDRA version: 14.1Level: LLTClassification code 10005046Term: Bladder incontinenceSystem Organ Class: 100000004857EUCTR2010-020944-37-GBniversity College London20
Recruiting
Not Applicable
COVID-19 ANTibody And T-cell AssaysACTRN12621000996864niversity of Otago3,000